Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours
Published Online: 2017-09-27
Journal: Nature•Publisher: Springer Science and Business Media LLC
Authors: Albert Lai•Arthur F. Kluge•Bailin Shaw•Brian T. Weinert•Ce Wang•Chaohong Sun•Chunaram Choudhary•Clarissa G. Jakob•David McElligott•Debra Ferguson•Debra Montgomery•Ed Kesicki•Emily Faivre•Enrico L. Digiammarino•Fritz G. Buchanan•Gary G. Chiang•J. William Langston•John H. Van Drie•Kannan Karukurichi•Kenneth D. Bromberg•Lloyd T. Lam•Loren M. Lasko•Maricel Torrent•Michael A. Patane•Michael R. Michaelides•Mikkel Algire•Paul Hessler•Peter de Vries•Philip A. Cole•Roberto M. Risi•Robin Frey•Rohinton P. Edalji•Ronen Marmorstein•Ruth L. Martin•Saul H. Rosenberg•T. Matt Hansen•Tamar Uziel•Vlasios Manaves•Wei Qiu
